Nirmatrelvir/ritonavir (Paxlovid) in the prevention of long-term cardiovascular outcomes: The paxloviD Effectiveness For the prEvention of loNg coviD (DEFEND) clinical trial
- Granting Agency
- Long COVID Web
- Principal Investigators
- Quinn K
- Co-Investigators
- Verma A, Razak F
- Grant Type
- Innovation Fund
- Grant Amount
- $100,000